Scott B. Seaman
President at ICT Holdings LLC
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
David Shanahan | M | - |
Gradalis, Inc.
Gradalis, Inc. Pharmaceuticals: MajorHealth Technology Gradalis, Inc. develops cancer therapies based on individuals tumor biology. The company was founded by David Shanahan and John Nemunaitis and is headquartered in Carrollton, TX. | - |
John Nemunaitis | M | - |
Gradalis, Inc.
Gradalis, Inc. Pharmaceuticals: MajorHealth Technology Gradalis, Inc. develops cancer therapies based on individuals tumor biology. The company was founded by David Shanahan and John Nemunaitis and is headquartered in Carrollton, TX. | - |
Steven Engle | M | 69 |
Gradalis, Inc.
Gradalis, Inc. Pharmaceuticals: MajorHealth Technology Gradalis, Inc. develops cancer therapies based on individuals tumor biology. The company was founded by David Shanahan and John Nemunaitis and is headquartered in Carrollton, TX. | 2 years |
Harry R. Jacobson | M | 76 |
Gradalis, Inc.
Gradalis, Inc. Pharmaceuticals: MajorHealth Technology Gradalis, Inc. develops cancer therapies based on individuals tumor biology. The company was founded by David Shanahan and John Nemunaitis and is headquartered in Carrollton, TX. | - |
Robert P. Landin | M | 54 |
Gradalis, Inc.
Gradalis, Inc. Pharmaceuticals: MajorHealth Technology Gradalis, Inc. develops cancer therapies based on individuals tumor biology. The company was founded by David Shanahan and John Nemunaitis and is headquartered in Carrollton, TX. | - |
Ernest Bognar | M | - |
Gradalis, Inc.
Gradalis, Inc. Pharmaceuticals: MajorHealth Technology Gradalis, Inc. develops cancer therapies based on individuals tumor biology. The company was founded by David Shanahan and John Nemunaitis and is headquartered in Carrollton, TX. | 9 years |
Joseph Cunningham | M | - |
Gradalis, Inc.
Gradalis, Inc. Pharmaceuticals: MajorHealth Technology Gradalis, Inc. develops cancer therapies based on individuals tumor biology. The company was founded by David Shanahan and John Nemunaitis and is headquartered in Carrollton, TX. | - |
JF Berry | M | - |
Gradalis, Inc.
Gradalis, Inc. Pharmaceuticals: MajorHealth Technology Gradalis, Inc. develops cancer therapies based on individuals tumor biology. The company was founded by David Shanahan and John Nemunaitis and is headquartered in Carrollton, TX. | - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Neil Warma | M | 61 |
Opexa Therapeutics, Inc.
Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | 9 years |
Lynne Hohlfeld | F | 64 |
PharmaFrontiers Corp.
Opexa Therapeutics, Inc.
Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | 3 years |
Michael Richman | M | 63 |
PharmaFrontiers Corp.
Opexa Therapeutics, Inc.
Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | 11 years |
Sandy Livney | F | - |
PharmaFrontiers Corp.
| - |
Jaye L. Thompson | M | 58 |
Opexa Therapeutics, Inc.
Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | 4 years |
C. William Rouse | M | - |
PharmaFrontiers Corp.
Opexa Therapeutics, Inc.
Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | - |
Gregory Bailey | M | 68 |
PharmaFrontiers Corp.
Opexa Therapeutics, Inc.
Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | 2 years |
Gail Maderis | F | 66 |
Opexa Therapeutics, Inc.
Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | 6 years |
Jim C. Williams | M | 80 |
PharmaFrontiers Corp.
Opexa Therapeutics, Inc.
Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | 5 years |
Kenny S. Frazier | M | - |
Opexa Therapeutics, Inc.
Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | - |
Timothy Barabe | M | 71 |
Opexa Therapeutics, Inc.
Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | 3 years |
Joseph Limber | M | 71 |
Gradalis, Inc.
Gradalis, Inc. Pharmaceuticals: MajorHealth Technology Gradalis, Inc. develops cancer therapies based on individuals tumor biology. The company was founded by David Shanahan and John Nemunaitis and is headquartered in Carrollton, TX. | 2 years |
David Jorden | M | 61 |
Opexa Therapeutics, Inc.
Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | 5 years |
David Hung | M | 66 |
Opexa Therapeutics, Inc.
Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | 5 years |
Hans-Peter Hartung | M | - |
Opexa Therapeutics, Inc.
Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | 3 years |
David McWilliams | M | 80 |
Opexa Therapeutics, Inc.
Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | 4 years |
Donald Healey | M | 62 |
Opexa Therapeutics, Inc.
Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | 7 years |
Anthony Kamin | M | 63 |
PharmaFrontiers Corp.
| - |
Scott Gottlieb | M | 51 |
Gradalis, Inc.
Gradalis, Inc. Pharmaceuticals: MajorHealth Technology Gradalis, Inc. develops cancer therapies based on individuals tumor biology. The company was founded by David Shanahan and John Nemunaitis and is headquartered in Carrollton, TX. | 2 years |
Dawn McGuire | M | 70 |
Opexa Therapeutics, Inc.
Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | - |
Karthik Radhakrishnan | M | 53 |
Opexa Therapeutics, Inc.
Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | 3 years |
Donna R. Rill | F | 70 |
PharmaFrontiers Corp.
| - |
Mitzi Martinez-Montgomery | M | - |
PharmaFrontiers Corp.
| - |
Terry H. Wesner | M | - |
PharmaFrontiers Corp.
| 1 years |
Brooks Boveroux | M | - |
PharmaFrontiers Corp.
| 1 years |
Jeff Randall | M | 80 |
Opexa Therapeutics, Inc.
Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | 2 years |
Paul Frison | M | - |
PharmaFrontiers Corp.
| - |
Sam Whiting | M | 58 |
Gradalis, Inc.
Gradalis, Inc. Pharmaceuticals: MajorHealth Technology Gradalis, Inc. develops cancer therapies based on individuals tumor biology. The company was founded by David Shanahan and John Nemunaitis and is headquartered in Carrollton, TX. | 2 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 36 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Scott B. Seaman
- Personal Network